[ALNY] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -41.32%
YoY- -21.46%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 220,553 177,566 163,562 125,853 103,962 99,476 71,681 111.69%
PBT -188,331 -199,275 -243,599 -252,452 -177,903 -181,646 -276,583 -22.61%
Tax 1,228 1,016 -59 839 1,326 575 -398 -
NP -189,559 -200,291 -243,540 -253,291 -179,229 -182,221 -276,185 -22.20%
Tax Rate - - - - - - - -
Total Cost 410,112 377,857 407,102 379,144 283,191 281,697 347,866 11.61%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -85.95 -112.80 -148.90 -201.26 -172.40 -183.18 -385.30 -63.25%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -1.61 -1.71 -2.09 -2.18 -1.56 -1.62 -2.47 -24.84%
EPS Diluted -1.61 -1.71 -2.09 -2.18 -1.56 -1.62 -2.47 -24.84%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.